Additional research revealed that APOA1 mimetic peptides might enhance cholesterol efflux, reduce lipoprotein oxidation, and promote the formation of pre-β HDL particles, making them a promising novel therapeutic strategy for atherosclerosis [80]. Here, APOA1 is linked to atherosclerosis.